
Prof. Dr. Thomas Klockgether
Neurologist
- With 28+ years of experience, Prof. Dr. Thomas Klockgether is a neurologist known for handling complex cases with ease.
- His clinical interest includes treatment of Parkinson’s disease, cerebrovascular disease, multiple sclerosis and headache disorders.
- He studied medicine at the University of Göttingen, Germany and also carried out research on Parkinson’s disease at the Max Planck Institute.
- After graduation, Prof. Klockgether went to Oldenburg for clinical training and completed his specialist training in degenerative ataxias at Tübingen.
- He has been Speaker of the Zentrum für seltene Erkrankungen Bonn (ZSEB) and is Director of Clinical Research at the DZNE.
- Prof. Klockgether has received numerous awards, including the C3‐Schilling professorship for theoretical and clinical medicine and the “Holmes Prize” of the Fondation de l’Ataxie cérébelleuse (FAC).
- He holds several scientific roles - coordinator of the clinical part of the EU-funded project EUROSCA, speaker of the DFG Research Group “Innate Immunity”, coordinator of the European RISCA project (E‐Rare program) and speaker of the Ataxia Study Group (ASG).
Show moreShow less
- With 28+ years of experience, Prof. Dr. Thomas Klockgether is a neurologist known for handling complex cases with ease.
- His clinical interest includes treatment of Parkinson’s disease, cerebrovascular disease, multiple sclerosis and headache disorders.
- He studied medicine at the University of Göttingen, Germany and also carried out research on Parkinson’s disease at the Max Planck Institute.
- After graduation, Prof. Klockgether went to Oldenburg for clinical training and completed his specialist training in degenerative ataxias at Tübingen.
- He has been Speaker of the Zentrum für seltene Erkrankungen Bonn (ZSEB) and is Director of Clinical Research at the DZNE.
- Prof. Klockgether has received numerous awards, including the C3‐Schilling professorship for theoretical and clinical medicine and the “Holmes Prize” of the Fondation de l’Ataxie cérébelleuse (FAC).
- He holds several scientific roles - coordinator of the clinical part of the EU-funded project EUROSCA, speaker of the DFG Research Group “Innate Immunity”, coordinator of the European RISCA project (E‐Rare program) and speaker of the Ataxia Study Group (ASG).
Showing 1–1 of 1 doctors
Get FREE Evaluation
Treatment plan and quote within 2 days






